Recovery is a journey of careful choices. When a doctor suggests a muscle relaxant like tizanidine (brand name Zanaflex), it’s natural to pause and ask: Is this safe for me?
Information about medications that affect the central nervous system is essential. This article breaks down tizanidine’s regulatory status and the real risks you need to discuss with your healthcare team before starting this medication.
- Tizanidine is NOT federally scheduled: In the U.S., tizanidine is currently not classified as a controlled substance by the DEA.
- High risk of misuse: Despite its non-controlled status, tizanidine is a central nervous system (CNS) depressant that carries a growing risk of misuse, especially in combination with other substances.
- Prioritize open dialogue: Always be upfront with your provider about your substance use history to ensure the safest treatment plan.
Is tizanidine a controlled substance?
Tizanidine is not currently scheduled as a controlled substance by the Drug Enforcement Administration (DEA) under the federal Controlled Substances Act (CSA). [1] The federal government assigns schedules (I through V) based on a drug's accepted medical use and its potential for abuse or dependence.
Drugs that are scheduled (like certain benzodiazepines or opioids) are subject to strict rules regarding prescribing, dispensing, and inventory. Because tizanidine does not meet the established criteria for federal scheduling, it doesn't face these same federal restrictions.
However, tizanidine's lack of scheduling does not mean the drug is without risk. Given its pharmacological profile, researchers have expressed concern about its growing availability and misuse. [1][2]
Abuse, dependence, and misuse risk of tizanidine
For anyone in recovery, understanding the risk of a medication is more important than its legal classification. Tizanidine acts as a central alpha-2 adrenergic agonist, essentially slowing down signals in the brain and nervous system to relax muscles. This mechanism results in significant sedation, making it a powerful central nervous system (CNS) depressant. [3]
The primary misuse of tizanidine is outside medical reasons, either for its sedative effects or, more dangerously, to potentiate (enhance) the effects of other substances, particularly opioids, benzodiazepines, or alcohol. [1]
Misuse can lead to severe side effects, including dangerously low blood pressure and extreme drowsiness. [3] Furthermore, abrupt cessation of tizanidine after chronic high-dose use can trigger a serious withdrawal syndrome, including anxiety, tremors, and rebound hypertension, which is a classic sign of physical dependence. [2] Recent research highlights that misuse potential is particularly elevated among individuals with a history of substance use disorder (SUD). [1]
Comparison with other muscle relaxants & scheduled drugs
When a doctor considers a muscle relaxant, they weigh the abuse potential against the therapeutic benefit.
| Drug name | Controlled status (US DEA) | Primary abuse concern |
|---|---|---|
| Tizanidine (Zanaflex) | Not Scheduled | Sedation, potentiation of opioids/CNS depressants [1] |
| Carisoprodol (Soma) | Schedule IV | Sedation, metabolizes to the controlled substance meprobamate [4] |
| Methocarbamol (Robaxin) | Not Scheduled | Generally considered to have low abuse potential |
Unlike tizanidine, the muscle relaxant carisoprodol was federally scheduled as a Schedule IV controlled substance in 2012 due to its history of diversion and abuse, and because it metabolizes into meprobamate, a known sedative of dependence. [4]Â
Conversely, methocarbamol interrupts the pain-spasm cycle without causing euphoria and possibly causing unpleasant effects at doses higher than what is medically recommended. [5] For these reasons, methocarbamol is considered to have a low-abuse potential. Tizanidine is not scheduled, but its growing misuse has placed it on the radar for close monitoring.
Safe prescribing and monitoring conditions
If you and your prescriber decide that tizanidine is necessary, safe use recommends the following: [3]
- Short-term use only: Tizanidine is intended for acute, short-term relief (typically 2 to 3 weeks).
- Avoid combinations: Never take tizanidine with alcohol, opioids, or benzodiazepines. The combination of CNS depressants can dangerously slow your breathing and heart rate.
- Monitor side effects: Be vigilant for severe dizziness, confusion, or hallucinations, and report them immediately.
- Do not stop abruptly: If you have been taking tizanidine regularly, speak to your prescriber about slowly tapering your dose to avoid withdrawal symptoms.
-Controlled-Substance-Status-guide-detail.jpg?v=1766989655)
